MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Upfront payment pursuant to four...
    • Proceeds from issuance of common...
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • Upfront payment pursuant to four...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-241,071
-39,339
-32,234
-36,932
Upfront payment pursuant to fourth amendment to license agreement
-200,000
-
-
-
Stock-based compensation
7,355
6,548
5,285
5,841
Accretion of discount on held-to-maturity securities
4,643
4,625
4,208
2,396
Amortization of debt discount and issuance costs related to senior secured term loan
126
-
-
-
Depreciation and amortization
5
6
13
15
Accrued interest receivable
-47
-289
181
-10
Prepaid, other current assets, and other assets
-1,958
1,948
-1,568
-3,560
Accounts payable and accrued liabilities
3,667
-402
-8,131
1,030
Net cash used in operating activities
-32,556
-39,471
-37,888
-28,872
Purchases of marketable securities
310,219
347,443
268,474
300,507
Maturities of marketable securities
325,000
302,500
165,000
150,000
Purchases of property and equipment
-
-
15
0
Upfront payment pursuant to fourth amendment to license agreement
200,000
-
-
-
Net cash used in investing activities
-185,219
-44,943
-103,489
-150,507
Proceeds from issuance of common stock in public offerings, net of offering costs and proceeds from issuance of common stock pursuant to atm agreement, net of atm issuance costs-Public Offering September2025
143,896
-
-317
270,200
Proceeds from senior secured term loan, net of debt discount and issuance costs with lender
97,503
-
-
-
Proceeds from issuance of common stock public offering, net of offering costs and proceeds from issuance of common stock pursuant to atm agreement, net of issuance costs-Public Offering March2025
-
-
0
188,880
Payment of debt issuance costs with third parties
1,015
-
-
-
Proceeds from issuance of common stock pursuant to atm agreement, net of issuance costs and proceeds from issuance of common stock public offering, net of offering costs-At The Market
-
20,218
92,262
18,393
Proceeds from issuance of common stock in public offerings, net of offering costs and proceeds from issuance of common stock pursuant to atm agreement, net of atm issuance costs-At The Market Agreement
20,218
-
-
-
Proceeds from stock option exercises
2,603
4,055
4,960
6,624
Proceeds from issuance of common stock for cash under employee stock purchase plan
292
-
101
0
Payment of shelf offering costs
15
1
305
29
Proceeds from issuance of common stock and pre-funded warrants in a private placement offering, net of offering costs
-
-
0
0
Proceeds from issuance of common stock pursuant to atm agreement, net of issuance costs and proceeds from issuance of common stock public offering, net of offering costs-Public Offering
-
-188,880
-
-
Net cash provided by financing activities
243,264
24,272
96,701
295,188
Net decrease in cash and cash equivalents
25,489
-60,142
-44,676
115,809
Cash and cash equivalents - beginning
112,779
172,921
217,597
114,091
Cash and cash equivalents - ending
138,268
112,779
172,921
217,597
Offering costs included in accounts payable and accrued liabilities
316
-
-
-
Accretion of exit consideration on senior secured term loan
17
-
-
-
Funds receivable from stock option exercises
13
-
-
-
Funds receivable from the sale of common stock pursuant to prior atm agreement, net of issuance costs
0
-
-
-
Investments
523,100
-
-
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock in public...$143,896K Proceeds from seniorsecured term loan, net of...$97,503K Proceeds from issuance ofcommon stock in public...$20,218K Proceeds from stockoption exercises$2,603K (116.56%↑ Y/Y)Proceeds from issuance ofcommon stock for cash...$292K (105.63%↑ Y/Y)Net cash provided byfinancing activities$243,264K (22.18%↑ Y/Y)Canceled cashflow$21,248K Net decrease in cashand cash...$25,489K (307.18%↑ Y/Y)Canceled cashflow$217,775K something is missing-$20,218K Payment of debt issuancecosts with third...$1,015K Payment of shelfoffering costs$15K (-73.68%↓ Y/Y)Maturities of marketablesecurities$325,000K (195.45%↑ Y/Y)Upfront paymentpursuant to fourth...-$200,000K Stock-based compensation$7,355K (-10.28%↓ Y/Y)Accounts payable andaccrued liabilities$3,667K (-51.29%↓ Y/Y)Prepaid, other currentassets, and other assets-$1,958K (-173.66%↓ Y/Y)Amortization of debt discountand issuance costs...$126K Accrued interestreceivable-$47K (-840.00%↓ Y/Y)Depreciation andamortization$5K (-83.87%↓ Y/Y)Net cash used ininvesting activities-$185,219K (-36.43%↓ Y/Y)Net cash used inoperating activities-$32,556K (56.97%↑ Y/Y)Canceled cashflow$325,000K Canceled cashflow$213,158K Purchases of marketablesecurities$310,219K (26.23%↑ Y/Y)Net loss-$241,071K (-182.00%↓ Y/Y)Upfront paymentpursuant to fourth...$200,000K Accretion of discount onheld-to-maturity securities$4,643K (41.77%↑ Y/Y)

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS)